Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with the infectious disease units at the John Radcliffe and Churchill Hospitals, the Vasudevan lab has identified a novel means of improving RT-qPCR sensitivity and efficiency for the detection of SARS-CoV-2 through the concentration of pooled patient lysates.

The SARS-CoV-2 virus has spread globally with over >95 million reported cases. Although, RT-qPCR has emerged as the gold-standard method for diagnosis, upscaling these tests to meet current demand is difficult. One means of reducing costs whilst simultaneously increasing throughput is to perform pooled testing. However, the main shortcoming of pooled testing lies in the loss of sensitivity associated with diluted samples, leading to false negative results. Here we report a new method  as a means of preserving and/or improving the sensitivity of pooled patient oro-nasopharyngeal lysates.. Comparing a spectrum of 340 COVID-19 positive and negative patients pooled lysates with individual PCR demonstrated that the loss in RT-qPCR sensitivity of pooled samples could be overcome with concentrators. We demonstrated that concentration of COVID-19 patient lysates could be successfully implemented for surveillance screening using pooling with minimal changes to standard workflow. Given that pooling reduces use of laboratory resources by up to 90% and only adds 15 minutes to the existing protocol, the described method will be indispensable for future surveillance testing. Given its simplicity, with no need for additional sophisticated instrumentation, our concentration approach could be used successfully to identify SARS-CoV-2 and other DNA/RNA pathogens (old and novel).


Similar stories

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.

New insight into the pharmacology of a therapeutic ion channel target

A new paper, published by the Tammaro lab in the Proceedings of the National Academy of Sciences (PNAS), shines new light on potential sites for pharmacological intervention within TMEM16A channels.

J Harold Burn (1892-1981)

A world-leading pharmacologist who built up the Department

New BHF study offers potential of new clinical options for cardiac treatment

A new study, led by Professor Kim Dora in association with Professor Raimondo Ascione at the University of Bristol, has shown abnormalities in the tiny blood vessels of human hearts which cannot be detected by current heart scans. Poor myogenic (automatic) tone, where blood flow in these vessels is abnormal, is thought to develop independent of disease in the larger arteries, which can be treated using stents or bypass surgeries.